Graduates

Global Health Catalyst Summit Outcome Example: Collaborative Education

 

Premier Hypofractionated Radiotherapy Education Course organized in collaboration with Radiation Knowledge

(July 8 -  September 3 2022)

Experts Lectures, treatment planning Olympics and practical training, Course Certificate/Awards

Course background and purpose:

Clinical trials have established clinical equipoise between hypofractionated radiotherapy (HFRT) schedules and conventionally fractionated treatment for some cancers like prostate and breast cancers. In the advent of the COVID-19 pandemic, professional societies including the American Society for Radiation Oncology and the National Comprehensive Cancer Network recommended increased adoption of evidence-based HFRT. HFRT benefits include significantly reducing  the number of clinical visits for each patient, minimizing potential exposure, and reducing costs and stress on limited workforce, which is particularly beneficial  in resource-limited settings or Low-and-Middle-Income Countries (LMICs).  Studies have also shown that increased adoption of HFRT could substantially increase access to care and reduce disparities. Despite the benefits, HFRT adoption remains low, especially in LMICs.  Education and training is a crucial consideration in the implementation and acceptance of a HFRT, and possibly just as critical to the development of HFRT as the technical infrastructure. Information and Communication Technologies (ICTs), and artificial intelligence (AI) technologies provide an excellent opportunity for facilitating education and training, and providing support for radiation oncology health professionals in increasing adoption of HFRT.


Cognizant of this,  the purpose of this course is to provide education and training in HFRT with major opportunity for professional development (with certificates and awards) leveraging ICTs/AI. The course will include lectures from experts at world-leading institutions, a treatment planning Olympics/competition (which in the past has drawn thousands of participants) and culminate with certificates and awards during the 2022 NIH-funded Global Health Catalyst summit 

deville-doctor.jpeg
bayview.jpeg
treatment plan.png
treatment plan2.jpg
 

Course Schedule

July 8 - September 3 2022

Online Class
treatment plan2.jpg

Weekly onine lectures (Saturdays)

July 8 – July 30th, 2022

  • July 8th, 2022: Session 1: General session on Hypofractionated Radiation therapy for breast, cervix, and prostate cancers. (Pre-course assessment for those interested in course certificates

  • July 16th, 2022: Session 2: Hypofractionated treatment workflow from consult to treatment for breast cancer

  • July 23rd, 2022: Session 3: Hypofractionated treatment workflow from consult to treatment for cervical cancer

  • July 30th, 2022: Session 4: Hypofractionated treatment workflow from consult to treatment for prostate cancer; Post-Lectures assessment for those interested in course completion certificates

Treatment Planning Activity/Competition on HFRT for prostate cancer, with awards

August 7th – September 3, 2022

  • August 7, 2022: Presentation about Contouring/Planning Activities: Presentation on the Contouring process, assignments, case description, plan criteria, plan evaluation, etc

  • August 8 – 9, 2022:  Contouring activity: Participants will perform homework/contouring tasks.

  • August 10-12, 2022: Planning activity: Participants downloads the case, generate plan (3D CRT &/or IMRT) in their TPS, upload & evaluate plan.

  • September 3, 2022. Announcement of statistics and winners, knowledge sharing, awards/certificates, and closing ceremony

 

Register for the hypofrationated Radiotherapy Course

 July 8, 2022 - September 3, 2022

arrow&v
Profession/Career track

Thanks for applying! We’ll be in touch soon.

 

Some of the Course Experts and collaborating team members amongst the world's best

Update in progress/Subject to Change

HUQ_SAIFUL_PHD.jpeg

Dr Saiful Huq

Professor, Radiation Oncology
and Clinical and Translational Science, Director, University of Pittsburgh School of Medicine, Past President, American Association of Physicists in Medicine

Akila.jpeg

Dr Akila Viswanathan

Chair, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Medicine

aver7961.jpg

Dr Stephen Avery

Associate Professor of Radiation Oncology. University of Pennsylvania

ahmed.png

Ahmad Nobah

Founder, Radiation Knowledge

Chipidza.jpeg

Dr Fallon Chipidza

Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School

Grover_Surbhi.jpeg

Dr Surbhi Grover

Assistant Professor and Director of Global Radiation Oncology, University of Pennsylvania

Jeff-Michalski.jpeg

Dr Jeff Michalski

Carlos Perez Distinguished Professor,  Department of Radiation Oncology, Washington University School of Medicine, ASTRO President-elect

May.jpeg

May Abdel-Wahab,

Director of the Division of Human Health at the International Atomic Energy Agency

curt.jpeg

Dr Curtiland Deville

Associate Professor of Radiation Oncology, Johns Hopkins Medicine

Dr.-Adedayo-Joseph.jpg

Dr Adedayo Joseph

Clinical Radiation Oncologist and the Research Program Director of NSIA-LUTH Cancer Centre,

amaka.png

Dr Nwamaka Lasebikan

President of Association of radiation and clinical oncologist of Nigeria

omoruyi-irabor-md-philadelphia-pa.jpeg

Dr Omoruyi, Credit Irabor

Radiation Oncology, Sidney Kimmel Cancer Center & Thomas Jefferson University Hospitals.

mandar-resize-e1631107117805.jpeg

Dr Mandar S Bhagwat

Massachusetts General Hospital, Harvard Medical School

ahmed.jpeg

Dr Ahmed Elzawawy

Professor of Clinical Oncology, Chair  of the Board of Directors. Global Oncology University

Heng.jpeg

Dr Heng Li

Associate Professor of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Medicine

Mack.png

Dr Mack Roach III

Professor of Radiation Oncology and Urology, at the University of California, San Francisco

rebeccabuecker.jpeg

Dr Rebecca Buecker

Senior Consultant Radiation Oncologist  Klinikum Lippe Lemgo, Germany. GHC Diaspora Global Radiation Oncology leader

taunk_neil.jpeg

Dr Neil Taunk

Assistant Professor of Radiation Oncology, University of Pennsylvania

 

Sponsors/Partners

RK Logo.png
educase.png
arcon.jpeg
 

Learn about more GHC summit outcomes